IDMA seeks exemptions for R&D, samples

Tags: News
Indian Drug Manufacturers' Association (IDMA) here today asked the government that 'control samples' and samples given to physicians be exempted from duties and taxes in the Budget.

The drug makers' body in a memorandum sent to the Finance Ministry also requested that all excisable goods used for Research and Development purposes should be exempted from Central Excise Duty, besides allowing exemption for capital goods, raw materials, consumables, and reference standards for R&D purposes.

"Pharma manufacturers are required to keep few boxes of each batch of medicine manufactured till its expiry as 'control samples', as per the provisions of the Drug and Cosmetic Act and Rules. These cannot be sold and hence, should be fully exempted from Central Excise Duty.

Similarly, medicine samples are provided to doctors as 'physician's samples', which should also be kept out of purview of all duties and taxes," IDMA said in the memorandum.

IDMA expects that the weighted deduction of 200 per cent of R&D expenses in an in-house facility will be extended for further period of five years, it said.

The industry body said in the last few Budget presentations, the pharma industry has been 'overlooked'.

"This year we expect the dynamic and forward thinking new government to create a transparent atmosphere of confidence and trust and provide suitable incentives and concessions to keep our growth momentum going." it said.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Copy the characters (respecting upper/lower case) from the image.

EDITORIAL OF THE DAY

  • State-owned banks can ride technology surge to penetrate retail segment

    For the first time in recent history, two large private sectors banks, ICICI and Axis have reduced their headcounts.

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

TODAY'S COLUMNS

Roopen Roy

Livability as a competitive advantage

Some CEOs and policymakers argue forcefully that distance is of ...

Rajgopal Nidamboor

The submarine element of your mind

We are all aware of the power of our will ...

Gautam Gupta

Retailers have it tough, thanks to e-commerce

For the past few months our focus has been on ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture